English | Español

Biospace
Patient Daily | Feb 5, 2026

Roche reports strong phase II results for obesity drug candidate CT-388
Patient Daily | Feb 5, 2026

Sarepta faces challenges as new Duchenne muscular dystrophy gene therapies near market
Patient Daily | Feb 4, 2026

Leaders urged to prioritize subtraction of old tasks for successful goal execution
Patient Daily | Feb 4, 2026

Lilly partners with Seamless Therapeutics on $1.12B+ gene editing deal for hearing loss
Patient Daily | Feb 4, 2026

Cellares raises $257M for expansion of automated cell therapy manufacturing
Patient Daily | Feb 4, 2026

Roche reports positive results in obesity drug trial; Moderna halts vaccine studies
Patient Daily | Feb 4, 2026

FDA holds up REGENXBIO's Hunter syndrome program; Denali may move ahead
Patient Daily | Feb 4, 2026

Cardiff Oncology faces executive departures and mixed phase II trial results

Trending
+ Marketing
A. K. Abreu | Jun 9, 2026

Patient in 5.0 Google review: Gulf Coast Breathe Free Sinus & Allergy Centers ‘changed my life’
Patient Daily | Jun 5, 2026

National Breathe Free donates $175,000 to support shelter for Tampa Bay families
+ Regulatory
Patient Daily News Service | Jun 9, 2026

New colon cancer blood test wins Medicare coverage, but trails stool-based screening in detecting precancerous lesions
+ Pharmaceuticals
Patient Daily | Jun 8, 2026

FDA rare disease framework faces uncertainty after leadership departures